| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Regulation, Leukemic | 8 | 2017 | 560 | 0.720 |
Why?
|
| Protein Kinase C | 5 | 2017 | 396 | 0.560 |
Why?
|
| Leukemia, Myeloid, Acute | 15 | 2021 | 6915 | 0.530 |
Why?
|
| Integrin alpha4beta1 | 1 | 2014 | 45 | 0.480 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 121 | 0.470 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2009 | 52 | 0.400 |
Why?
|
| Drug Resistance, Neoplasm | 8 | 2016 | 5178 | 0.400 |
Why?
|
| NF-kappa B | 3 | 2016 | 1549 | 0.400 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2007 | 161 | 0.340 |
Why?
|
| Phosphoserine | 1 | 2008 | 107 | 0.320 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2009 | 488 | 0.310 |
Why?
|
| Hypoxia | 2 | 2022 | 443 | 0.290 |
Why?
|
| Tyrosine | 2 | 2007 | 498 | 0.280 |
Why?
|
| Serine | 1 | 2007 | 388 | 0.260 |
Why?
|
| Signal Transduction | 11 | 2022 | 11965 | 0.250 |
Why?
|
| Heat Shock Transcription Factors | 2 | 2021 | 51 | 0.230 |
Why?
|
| Cell Adhesion | 4 | 2022 | 1008 | 0.230 |
Why?
|
| Cell Movement | 3 | 2016 | 2466 | 0.230 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2014 | 202 | 0.230 |
Why?
|
| Cytoskeletal Proteins | 2 | 2016 | 492 | 0.220 |
Why?
|
| Apoptosis | 11 | 2019 | 7591 | 0.220 |
Why?
|
| Tumor Microenvironment | 5 | 2021 | 2864 | 0.220 |
Why?
|
| Cell Line, Tumor | 15 | 2020 | 14551 | 0.210 |
Why?
|
| Mitochondrial Proteins | 2 | 2014 | 369 | 0.200 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2021 | 13 | 0.200 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2012 | 376 | 0.200 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2017 | 482 | 0.200 |
Why?
|
| Phosphorylation | 9 | 2017 | 4804 | 0.190 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 253 | 0.180 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2020 | 28 | 0.180 |
Why?
|
| Mice | 19 | 2022 | 34495 | 0.170 |
Why?
|
| DNA Damage | 2 | 2017 | 1954 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 1265 | 0.160 |
Why?
|
| Coculture Techniques | 3 | 2014 | 626 | 0.160 |
Why?
|
| Thiazolidines | 2 | 2015 | 16 | 0.160 |
Why?
|
| Protein Array Analysis | 2 | 2018 | 501 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 848 | 0.150 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2014 | 801 | 0.150 |
Why?
|
| Animals | 21 | 2022 | 59536 | 0.150 |
Why?
|
| Mice, Inbred NOD | 6 | 2016 | 905 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 2 | 2016 | 1491 | 0.150 |
Why?
|
| Cdh1 Proteins | 1 | 2017 | 18 | 0.150 |
Why?
|
| Dipeptides | 2 | 2014 | 91 | 0.150 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 538 | 0.150 |
Why?
|
| Benzeneacetamides | 1 | 2016 | 28 | 0.150 |
Why?
|
| Leukemia | 2 | 2015 | 1635 | 0.150 |
Why?
|
| Sulfides | 1 | 2016 | 48 | 0.150 |
Why?
|
| Thiadiazoles | 1 | 2016 | 47 | 0.140 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 122 | 0.140 |
Why?
|
| Glutaminase | 1 | 2016 | 47 | 0.140 |
Why?
|
| Neoplasm Proteins | 3 | 2018 | 3230 | 0.140 |
Why?
|
| Epithelial Cells | 3 | 2010 | 1818 | 0.140 |
Why?
|
| Cell Line, Transformed | 2 | 2014 | 394 | 0.140 |
Why?
|
| Bone Marrow | 2 | 2015 | 2358 | 0.140 |
Why?
|
| Antineoplastic Agents | 6 | 2021 | 14289 | 0.140 |
Why?
|
| Adenylate Kinase | 1 | 2015 | 36 | 0.140 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2016 | 73 | 0.130 |
Why?
|
| Phosphoramide Mustards | 1 | 2015 | 37 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2015 | 45 | 0.130 |
Why?
|
| Mice, SCID | 6 | 2016 | 1869 | 0.130 |
Why?
|
| Nitroimidazoles | 1 | 2015 | 100 | 0.130 |
Why?
|
| Imidazoles | 3 | 2016 | 999 | 0.130 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 3 | 2019 | 923 | 0.130 |
Why?
|
| Indoles | 4 | 2014 | 1009 | 0.130 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2016 | 119 | 0.130 |
Why?
|
| Endothelial Cells | 2 | 2014 | 1048 | 0.130 |
Why?
|
| Glutamine | 1 | 2016 | 299 | 0.130 |
Why?
|
| Exosomes | 1 | 2018 | 253 | 0.130 |
Why?
|
| Proteomics | 2 | 2019 | 1380 | 0.130 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 300 | 0.130 |
Why?
|
| Chemokine CXCL12 | 2 | 2013 | 132 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2015 | 507 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2014 | 621 | 0.120 |
Why?
|
| Biphenyl Compounds | 1 | 2015 | 194 | 0.120 |
Why?
|
| Prodrugs | 1 | 2015 | 217 | 0.120 |
Why?
|
| Morpholines | 1 | 2015 | 289 | 0.120 |
Why?
|
| Protein Phosphatase 2 | 1 | 2014 | 88 | 0.120 |
Why?
|
| Oxygen | 2 | 2022 | 754 | 0.120 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 197 | 0.120 |
Why?
|
| Enzyme Activation | 4 | 2015 | 1764 | 0.120 |
Why?
|
| Caspase 8 | 1 | 2014 | 145 | 0.120 |
Why?
|
| Cell Membrane | 1 | 2017 | 850 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2019 | 1493 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2017 | 4757 | 0.110 |
Why?
|
| Cell Nucleus | 2 | 2017 | 1620 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2015 | 1546 | 0.110 |
Why?
|
| Models, Animal | 2 | 2012 | 664 | 0.110 |
Why?
|
| Lymphoma, B-Cell | 1 | 2020 | 895 | 0.110 |
Why?
|
| Cell Proliferation | 6 | 2018 | 7226 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2012 | 460 | 0.110 |
Why?
|
| Transplantation, Heterotopic | 1 | 2012 | 43 | 0.110 |
Why?
|
| Cellular Microenvironment | 1 | 2012 | 41 | 0.110 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2012 | 41 | 0.100 |
Why?
|
| Cytoskeleton | 3 | 2010 | 267 | 0.100 |
Why?
|
| Sulfonamides | 3 | 2019 | 1823 | 0.100 |
Why?
|
| Gangliosides | 1 | 2012 | 95 | 0.100 |
Why?
|
| Caspases | 1 | 2014 | 661 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 639 | 0.100 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2017 | 323 | 0.100 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 269 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2015 | 3552 | 0.100 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 1879 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 5 | 2018 | 5395 | 0.100 |
Why?
|
| Cell Line | 5 | 2017 | 5114 | 0.100 |
Why?
|
| Bone Marrow Cells | 2 | 2012 | 943 | 0.100 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2010 | 14 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2016 | 992 | 0.090 |
Why?
|
| Humans | 33 | 2022 | 261506 | 0.090 |
Why?
|
| Catalysis | 2 | 2008 | 250 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2014 | 619 | 0.090 |
Why?
|
| COS Cells | 2 | 2008 | 377 | 0.090 |
Why?
|
| Muscle Proteins | 1 | 2014 | 549 | 0.090 |
Why?
|
| Spindle Apparatus | 1 | 2010 | 93 | 0.090 |
Why?
|
| Centrosome | 1 | 2010 | 95 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 345 | 0.090 |
Why?
|
| Blotting, Western | 5 | 2015 | 3536 | 0.090 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2016 | 713 | 0.090 |
Why?
|
| Stromal Cells | 1 | 2014 | 825 | 0.090 |
Why?
|
| MicroRNAs | 2 | 2014 | 2947 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2014 | 5637 | 0.090 |
Why?
|
| Fibroblasts | 2 | 2007 | 1682 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2015 | 6150 | 0.090 |
Why?
|
| Mutation | 6 | 2016 | 15179 | 0.090 |
Why?
|
| Autophagy | 1 | 2015 | 927 | 0.090 |
Why?
|
| Piperazines | 2 | 2015 | 2101 | 0.080 |
Why?
|
| Pyridines | 2 | 2016 | 1244 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2010 | 284 | 0.080 |
Why?
|
| Biomarkers, Tumor | 3 | 2018 | 10331 | 0.080 |
Why?
|
| Pyrimidines | 4 | 2016 | 3518 | 0.080 |
Why?
|
| HLA-A Antigens | 1 | 2008 | 102 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 2 | 2014 | 1443 | 0.080 |
Why?
|
| Antimetabolites, Antineoplastic | 4 | 2014 | 1299 | 0.080 |
Why?
|
| Cytochalasin D | 1 | 2007 | 19 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 1678 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 1581 | 0.070 |
Why?
|
| Cell Shape | 1 | 2007 | 128 | 0.070 |
Why?
|
| Colon | 1 | 2010 | 670 | 0.070 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 1724 | 0.070 |
Why?
|
| Mitosis | 1 | 2009 | 615 | 0.070 |
Why?
|
| Integrins | 1 | 2008 | 262 | 0.070 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2007 | 111 | 0.070 |
Why?
|
| Focal Adhesions | 1 | 2006 | 45 | 0.070 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2020 | 280 | 0.070 |
Why?
|
| Lysophospholipids | 1 | 2006 | 147 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 5159 | 0.070 |
Why?
|
| Transplantation, Heterologous | 3 | 2012 | 1082 | 0.060 |
Why?
|
| Piperidines | 2 | 2021 | 1035 | 0.060 |
Why?
|
| Kinetics | 1 | 2008 | 2049 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 1870 | 0.060 |
Why?
|
| Calcium | 1 | 2010 | 1537 | 0.060 |
Why?
|
| Rats | 2 | 2017 | 6086 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2014 | 2669 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2008 | 874 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 2216 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 803 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 4821 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2016 | 3821 | 0.050 |
Why?
|
| Intestines | 1 | 2006 | 686 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2015 | 5270 | 0.050 |
Why?
|
| Oxadiazoles | 1 | 2021 | 57 | 0.050 |
Why?
|
| Cell Survival | 3 | 2014 | 3045 | 0.050 |
Why?
|
| Mitochondrial Dynamics | 1 | 2021 | 62 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2014 | 1313 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 4233 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5061 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2018 | 2283 | 0.050 |
Why?
|
| Neoplasm Transplantation | 2 | 2014 | 1519 | 0.040 |
Why?
|
| Protein Isoforms | 2 | 2016 | 842 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 10035 | 0.040 |
Why?
|
| Time Factors | 3 | 2009 | 12926 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2015 | 3033 | 0.040 |
Why?
|
| Azetidines | 1 | 2019 | 87 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 2796 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 4143 | 0.040 |
Why?
|
| Gene Expression | 2 | 2020 | 3570 | 0.040 |
Why?
|
| src-Family Kinases | 2 | 2014 | 478 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 2330 | 0.040 |
Why?
|
| Protein Binding | 2 | 2020 | 3438 | 0.040 |
Why?
|
| Glutamate Dehydrogenase | 1 | 2016 | 14 | 0.040 |
Why?
|
| Cytarabine | 2 | 2014 | 1973 | 0.040 |
Why?
|
| Liquid Biopsy | 1 | 2018 | 158 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2007 | 5710 | 0.040 |
Why?
|
| Glutarates | 1 | 2016 | 44 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 342 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2018 | 4078 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2012 | 703 | 0.040 |
Why?
|
| RNA Interference | 2 | 2014 | 1408 | 0.040 |
Why?
|
| Actins | 2 | 2010 | 608 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 8873 | 0.030 |
Why?
|
| Genes, bcl-2 | 1 | 2015 | 166 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 368 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 208 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 252 | 0.030 |
Why?
|
| Lentivirus | 1 | 2015 | 169 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2016 | 309 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 7222 | 0.030 |
Why?
|
| Propylene Glycols | 1 | 2014 | 36 | 0.030 |
Why?
|
| Adult | 6 | 2020 | 77950 | 0.030 |
Why?
|
| Sphingosine | 1 | 2014 | 55 | 0.030 |
Why?
|
| Mitochondria | 1 | 2021 | 1282 | 0.030 |
Why?
|
| Cell Death | 1 | 2017 | 671 | 0.030 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2014 | 45 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 4638 | 0.030 |
Why?
|
| Middle Aged | 6 | 2020 | 86204 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 597 | 0.030 |
Why?
|
| Protein Kinase C-alpha | 1 | 2014 | 66 | 0.030 |
Why?
|
| Cytoplasm | 2 | 2007 | 652 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2012 | 2054 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 984 | 0.030 |
Why?
|
| YY1 Transcription Factor | 1 | 2013 | 18 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2014 | 201 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 663 | 0.030 |
Why?
|
| Male | 6 | 2022 | 123000 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 2013 | 196 | 0.030 |
Why?
|
| Sialyltransferases | 1 | 2012 | 23 | 0.030 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2016 | 480 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 461 | 0.030 |
Why?
|
| Aged | 5 | 2020 | 70117 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2012 | 47 | 0.030 |
Why?
|
| CD24 Antigen | 1 | 2012 | 85 | 0.030 |
Why?
|
| Niacinamide | 1 | 2014 | 421 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2012 | 131 | 0.030 |
Why?
|
| Drug Design | 1 | 2014 | 375 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2014 | 421 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 1217 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 15862 | 0.030 |
Why?
|
| Female | 7 | 2020 | 141928 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 328 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2012 | 249 | 0.020 |
Why?
|
| Point Mutation | 1 | 2014 | 769 | 0.020 |
Why?
|
| TRPC Cation Channels | 1 | 2010 | 16 | 0.020 |
Why?
|
| Filamins | 1 | 2010 | 33 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 777 | 0.020 |
Why?
|
| Contractile Proteins | 1 | 2010 | 43 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2014 | 580 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2012 | 271 | 0.020 |
Why?
|
| Benzamides | 1 | 2015 | 1832 | 0.020 |
Why?
|
| Precision Medicine | 1 | 2018 | 1154 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 1062 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2015 | 1152 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 2315 | 0.020 |
Why?
|
| Swiss 3T3 Cells | 1 | 2009 | 5 | 0.020 |
Why?
|
| Bombesin | 1 | 2009 | 15 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 810 | 0.020 |
Why?
|
| Maleimides | 1 | 2009 | 22 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 519 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2010 | 177 | 0.020 |
Why?
|
| Vasopressins | 1 | 2009 | 62 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1077 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 3639 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 854 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 1538 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2009 | 159 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 6295 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2009 | 151 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 6100 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 15694 | 0.020 |
Why?
|
| Azacitidine | 1 | 2014 | 1149 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2010 | 487 | 0.020 |
Why?
|
| Cytochalasins | 1 | 2007 | 1 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 2007 | 47 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 1987 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 2508 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2007 | 158 | 0.020 |
Why?
|
| Pseudopodia | 1 | 2006 | 30 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 973 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 1248 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 1533 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 2074 | 0.020 |
Why?
|
| beta Karyopherins | 1 | 2005 | 36 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 852 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 4938 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2005 | 355 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 3254 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 644 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2005 | 227 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 611 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 12221 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2010 | 2084 | 0.020 |
Why?
|
| Transcriptome | 1 | 2013 | 1859 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 591 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 13658 | 0.020 |
Why?
|
| Temperature | 1 | 2005 | 506 | 0.020 |
Why?
|
| Plasmids | 1 | 2005 | 837 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2010 | 1996 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2014 | 2819 | 0.010 |
Why?
|
| Young Adult | 2 | 2012 | 21445 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 769 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 1487 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2007 | 1152 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 7548 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2012 | 9180 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 2944 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 2009 | 2295 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 1555 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 21713 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 7702 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 4917 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 6089 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 13310 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 16273 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 32848 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 29902 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 31252 | 0.010 |
Why?
|
| Child | 1 | 2012 | 29154 | 0.010 |
Why?
|